A Trial to Assess the Safety, Tolerability, and Pharmacokinetics of the Anti-Orthopoxvirus Compound Tecovirimat
Public ClinicalTrials.gov record NCT02474589. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Expanded Double-Blind, Placebo Controlled, Multicenter Trial to Assess the Safety, Tolerability, and Pharmacokinetics of the Anti Orthopoxvirus Compound Tecovirimat When Administered Orally for 14 Days in Subjects
Study identification
- NCT ID
- NCT02474589
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- SIGA Technologies
- Industry
- Enrollment
- 449 participants
Conditions and interventions
Conditions
Interventions
- tecovirimat Drug
- Placebo Other
Drug · Other
Eligibility (public fields only)
- Age range
- 18 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 18, 2015
- Primary completion
- Aug 23, 2016
- Completion
- Aug 23, 2016
- Last update posted
- Nov 27, 2017
2015 – 2016
United States locations
- U.S. sites
- 11
- U.S. states
- 7
- U.S. cities
- 11
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Coastal Clinical Research, Inc. | Mobile | Alabama | 36608 | — |
| Paradigm Research | Redding | California | 96001 | — |
| Paradigm Research | San Diego | California | 92117 | — |
| Johnson County Clinical Trials | Lenexa | Kansas | 66219 | — |
| Heartland Research Associates, LLC | Newton | Kansas | 67114 | — |
| Center for Pharmaceutical Research | Kansas City | Missouri | 64114 | — |
| Sundance Clinical Research LLC | St Louis | Missouri | 63141 | — |
| Meridien Clinical Research | Omaha | Nebraska | 68134 | — |
| Medical Research South | Charleston | South Carolina | 29407 | — |
| Benchmark Research | Austin | Texas | 78705 | — |
| Benchmark Research | Fort Worth | Texas | 76135 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02474589, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 27, 2017 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02474589 live on ClinicalTrials.gov.